A major structural failure at the former Pfizer headquarters in Midtown Manhattan prompted emergency evacuations and the closure of several city blocks on Tuesday morning. Steel beams in the building’s middle floors nearly snapped, forcing officials to clear the tower and surrounding properties while engineers worked to stabilize the site. While residents were allowed to return to some nearby buildings by Tuesday evening, the incident has raised questions regarding the safety of ongoing office-to-residential conversion projects in New York City.
Why the Pfizer building failure is significant
The incident at the Midtown tower is notable because it occurred during a widespread push to repurpose aging office space into housing. According to Department of City Planning data, more than 3,000 apartments and condos have been added to the city’s housing stock through these conversions since 2020, with another 2,000 currently under construction. City officials have incentivized these projects with tax breaks and rezoning measures, such as the recent change to a 42-block section of Manhattan between West 23rd and West 40th streets, to address the city’s housing shortage.
Did You Know? City building codes generally require office structures to support higher weights per square foot than residential buildings, meaning that, in theory, commercial structures should handle the transition to residential use well, according to engineer Eric Cowley.
Expert analysis on conversion risks
Engineers and legal experts are currently examining the cause of the failure. Eugene Gurevich, a principal and forensics team leader at the engineering firm RAND, noted that the conversion process is highly rigorous. He stated that developers must conduct intensive investigation and analysis of older structural components to ensure they meet current rules, a process monitored by the Department of Buildings. “In some ways, it’s more difficult than new construction because you have to figure out what you have before you can figure out what you can do,” Gurevich said.
Attorney Michael De Chiara, who represents developers, engineers and government agencies in construction disputes, suggested that the incident is unlikely to halt future conversion plans. “It should have no impact on those projects going forward because this is something that rarely, rarely happens and we have to understand what the real mechanism was,” De Chiara said. He added that the investigation will determine if the failure was design-related, construction-related, or both.
Expert Insight: The distinction between this incident and previous structural collapses in New York—such as the 2023 parking garage failure in Lower Manhattan caused by unsafe demolition and neglect or the Bronx apartment collapse involving the removal of load-bearing bricks—is critical.
What happens next for the site
Engineers are currently working to stabilize the structure, and the site remains under scrutiny. Representatives for the developer, Metroloft, and the architecture firm, Gensler, have declined to comment on potential causes. Similarly, the engineer listed on the building's applications, Christopher Behan of GACE Consulting Engineers, has not responded to requests for comment.
Frequently Asked Questions
What caused the structural failure at the Pfizer building?
The exact cause remains under investigation. Experts state it is either design-related, construction-related, or both, but a definitive determination has not yet been reached.
Are office-to-residential conversions common in New York?
Yes. Since 2020, more than 3,000 apartments and condos have been created through these conversions, with over 2,000 more currently in progress.
Will this incident stop other housing conversion projects?
Legal experts involved in construction disputes do not expect this to hinder other projects, noting that such structural failures are rare.
How will this event change the way New Yorkers perceive the safety of living in converted office towers?
